2024 Titanium Dioxide Industry Report: Total Production Reaches 4.766 Million Tons, Up 14.57%
According to recent statistics from the Titanium Dioxide Industry Technology Innovation Strategic Alliance, there are 42 titanium dioxide production companies with normal operating conditions in 2024 (excluding post-processing firms). These companies produced a total of 4.766 million tons of rutile and anatase titanium dioxide and related products, an increase of 606,000 tons, reflecting a 14.57% growth compared to the previous year.
Of the total production volume of 4.766 million tons, rutile products accounted for the majority at 4.051 million tons, making up 85% of the total, though this represents a decline of 1.54 percentage points from last year. Anatase products reached 560,000 tons, comprising 11.75% of the total, marking an increase of 1.64 percentage points. Non-pigment and other types of products totaled 156,000 tons, representing 3.27%, down by 0.1 percentage points.
The chloride process products amounted to 663,000 tons, a decrease of 29,000 tons from the previous year, which corresponds to a 4.19% decline. This is the first annual drop in chloride production in recent years. In 2024, chloride products accounted for 13.91% of the total titanium dioxide production, down 2.72 percentage points year-on-year, and 16.37% of rutile production, also down 2.85 percentage points.
Among the 40 comparable production companies, 10 experienced a year-on-year decrease in output, while most others increased production, with a few remaining stable. Additionally, 2 existing manufacturers ceased operations, while 2 new companies began production.
Overall, the average capacity utilization rate for the titanium dioxide industry in 2024 stands at 80.64%, indicating a significant overcapacity issue within the sector.
2026-10-18
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
FDA Fee Updates Raise the Cost of Entering the U.S. Generic Drug Chain
-
FDA Dye Pledges Push Natural Colors Into the Mainstream
-
FDA’s Warning to Compounders Raises the Stakes for API and Excipient Suppliers
-
Trump Urges Ukraine to Halt Russian Refinery Strikes as Diesel Shortage Becomes a Global Policy Issue
-
关于全面排查下架易制毒及易制爆产品信息的公告 Announcement on the Comprehensive Review and Removal of Product Information Related to Precursor and Explosive Precursor Chemicals
-
U.S. and China Reach Consensus on More Favorable Tariff Treatment for $30 Billion of Goods Each Way
-
U.S. Section 232 Pharmaceutical Tariffs Take Effect, With 100% Base Rate on Patented Drugs and APIs
-
3M, DuPont and Honeywell Must Face Firefighters’ PFAS Turnout-Gear Lawsuit
-
EAEU Initiates Review of Anti-Dumping Measures on Chinese Titanium Dioxide, Suspends Duties During Investigation
-
UK Opens Formal Review of AkzoNobel–Axalta $25 Billion Merger
Recommend Reading
-
U.S. Congress Passes Bill Authorizing Tariffs of Up to 100% on Major Buyers of Russian Energy
-
Pakistan Launches Successive Anti-dumping Investigations against Chinese Products, Involving Soda Ash, Ibuprofen and Other Raw Materials
-
U.S. FDA Opens New Safety Review of RSV Treatments for Infants
-
The FDA Officially Blesses AI for Liver Drug Development
-
U.S. Formally Imposes Antidumping and Countervailing Duty Orders on Chinese L-Lysine
-
Spread Widens as Shandong Cyclohexanone Market Prices Continue to Decline in May
-
Business Society’s Acrylic Acid Trend Analysis for September 14, 2026: Strong Consolidation
-
Supply-Demand Mismatch: Acrylonitrile Market Stagnant and Relatively Weak in May
-
Business Society’s Trend Analysis for Isooctanol on September 14, 2026: Strong Consolidation
-
Premium Global Chemical Sourcing Requests (8-11Oct.,2026)